CoChat
Sign Up
Cited by 91

Prognostic Significance of miR-215 in Colon Cancer

Karaayvaz, Mihriban, Pal, Timothy, Song, Bo, Zhang, Cecilia, Georgakopoulos, Penelope, Mehmood, Saira, Burke, Stephanie, Shroyer, Kenneth +1 more·2011·Clinical Colorectal Cancer
DOI 10.1016/j.clcc.2011.06.002PMC PMC3390153
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.clcc.2011.06.002

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A significant decrease in expression of miR-192-5p in colorectal cancer compared to normal mucosa has been reported (22).

    “A significant decrease in expression of miR-192–5p in colorectal cancer compared to normal mucosa has been reported (22).”

    From Distribution of miRNA expression across human tissues (2016) · cites this paper as [22]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 43

  1. [1]Hamilton SR Vogelstein B Kudo S Aaltonen LA Hamilton SR Tumors of the colon and rectum Pathology and Genetics of Tumours of the Digestive System Oxford IARC Press, Oxford University Press (distributor, Lyon Oxford) 2000 314
  2. [2]McLornan DP Barrett HL Cummins R Prognostic significance of TRAIL signaling molecules in stage II and III colorectal cancer Clin Cancer Res 2010 16 3442 51 20570920 PMC2896551
  3. [3]O’Connell JB Maggard MA Ko CY Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 2004 96 1420 5 15467030
  4. [4]Longley DB Allen WL Johnston PG Drug resistance, predictive markers and pharmacogenomics in colorectal cancer Biochim Biophys Acta 2006 1766 184 96 16973289
  5. [5]Chu E Copur SM Ju J Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex Mol Cell Biol 1999 19 1582 94 9891091 PMC116086
  6. [6]Ju J Pedersen-Lane J Maley F Chu E Regulation of p53 expression by thymidylate synthase Proc Natl Acad Sci U S A 1999 96 3769 74 10097112 PMC22369
  7. [7]Sheikh MS Fornace AJ Jr Regulation of translation initiation following stress Oncogene 1999 18 6121 8 10557103
  8. [8]Ju J Huang C Minskoff SA Simultaneous gene expression analysis of steady-state and actively translated mRNA populations from osteosarcoma MG-63 cells in response to IL-1α via an open expression analysis platform Nucleic Acids Res 2003 31 5157 66 12930967 PMC212802
  9. [9]Fu L Minden MD Benchimol S Translational regulation of human p53 gene expression EMBO J 1996 15 4392 401 8861966 PMC452163
  10. [10]Chu E Koeller DM Casey JL Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase Proc Natl Acad Sci U S A 1991 88 8977 81 1924359 PMC52634
  11. [11]Lee RC Feinbaum RL Ambros V The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 1993 75 843 54 8252621
  12. [12]Brennecke J Hipfner DR Stark A bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila Cell 2003 113 25 36 12679032
  13. [13]Chan JA Krichevsky AM Kosik KS MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells Cancer Res 2005 65 6029 33 16024602
  14. [14]Ghodgaonkar MM Shah RG Kandan-Kulangara F Abrogation of DNA vector-based RNAi during apoptosis in mammalian cells due to caspase-mediated cleavage and inactivation of Dicer-1 Cell Death Differ 2009 16 858 68 19229243
  15. [15]Hwang HW Mendell JT MicroRNAs in cell proliferation, cell death, and tumorigenesis Br J Cancer 2006 94 776 80 16495913 PMC2361377
  16. [16]Tang F Small RNAs in mammalian germline: tiny for immortal Differentiation 2010 79 141 6 20227007
  17. [17]Navarro F Lieberman J Small RNAs guide hematopoietic cell differentiation and function J Immunol 2010 184 5939 47 20483778
  18. [19]He L Thomson JM Hemann MT A microRNA polycistron as a potential human oncogene Nature 2005 435 828 33 15944707 PMC4599349
  19. [20]Johnson CD Esquela-Kerscher A Stefani G The let-7 microRNA represses cell proliferation pathways in human cells Cancer Res 2007 67 7713 22 17699775
  20. [21]Lu J Getz G Miska EA MicroRNA expression profiles classify human cancers Nature 2005 435 834 8 15944708
  21. [22]Volinia S Calin GA Liu CG A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci U S A 2006 103 2257 61 16461460 PMC1413718
  22. [23]Braun CJ Zhang X Savelyeva I p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest Cancer Res 2008 68 10094 104 19074875 PMC2836584
  23. [24]Xi Y Shalgi R Fodstad O Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer Clin Cancer Res 2006 12 2014 24 16609010
  24. [25]He L He X Lim LP A microRNA component of the p53 tumour suppressor network Nature 2007 447 1130 4 17554337 PMC4590999
  25. [26]He X He L Hannon GJ The guardian’s little helper: microRNAs in the p53 tumor suppressor network Cancer Res 2007 67 11099 101 18056431
  26. [28]Corney DC Flesken-Nikitin A Godwin AK MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth Cancer Res 2007 67 8433 8 17823410
  27. [29]Tarasov V Jung P Verdoodt B Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest Cell Cycle 2007 6 1586 93 17554199
  28. [30]Song B Wang Y Titmus M Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells Mol Cancer 2010 9 96 20433742 PMC2881118
  29. [31]Fujita Y Kojima K Hamada N Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells Biochem Biophys Res Commun 2008 377 114 9 18834855
  30. [32]Yang H Kong W He L MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN Cancer Res 2008 68 425 33 18199536
  31. [33]Song B Wang Y Xi Y Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells Oncogene 2009 28 4065 74 19734943 PMC2783211
  32. [34]Song B Wang Y Kudo K miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit Clin Cancer Res 2008 14 8080 6 19088023 PMC2653201
  33. [35]Showalter SL Showalter TN Witkiewicz A Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil. Is it time to move forward? Cancer Biol Ther 2008 7 986 94 18443433 PMC3081718
  34. [36]Pan HW Chou HY Liu SH Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma Cell Cycle 2006 5 2676 87 17106265
  35. [37]Higa LA Banks D Wu M L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage Cell Cycle 2006 5 1675 80 16861906
  36. [38]Sansam CL Shepard JL Lai K DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint Genes Dev 2006 20 3117 29 17085480 PMC1635147
  37. [39]Banks D Wu M Higa LA L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes Cell Cycle 2006 5 1719 29 16861890
  38. [40]Nishitani H Shiomi Y Iida H CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation J Biol Chem 2008 283 29045 52 18703516 PMC2662008
  39. [41]Shibutani ST de la Cruz AF Tran V Intrinsic negative cell cycle regulation provided by PIP box- and Cul4Cdt2-mediated destruction of E2f1 during S phase Dev Cell 2008 15 890 900 19081076 PMC2644461
  40. [42]Xi Y Formentini A Chien M Prognostic values of microRNAs in colorectal cancer Biomark Insights 2006 2 113 21 18079988 PMC2134920
  41. [43]Xi Y Nakajima G Gavin E Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples RNA 2007 13 1668 74 17698639 PMC1986820
  42. [44]Singh M Spoelstra NS Jean A ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease Mod Pathol 2008 21 912 23 18487993
  43. [45]Brody JR Hucl T Costantino CL Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influence Cancer Res 2009 69 984 91 19155291 PMC2887094

Cited by

Sorted by citations

Authors
Karaayvaz, M., Pal, T., Song, B., Zhang, C., Georgakopoulos, P., Mehmood, S., Burke, S., Shroyer, K., & Ju, J.
Venue
Clinical Colorectal Cancer
Publisher
Elsevier BV
Published
2011-12
Volume
10
Issue
4
Pages
340-347
ISSN
1533-0028
DOI
10.1016/j.clcc.2011.06.002
PMC
PMC3390153
Cited by
91
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review